top of page

Who we are

Novocuff, Inc. is a medical device company dedicated to improving pregnancy outcomes and reducing preterm births caused by PPROM and cervical shortening.   

Why it matters

Preterm birth is the leading cause of death for infants under the age of one. According to the World Health Organization (WHO), preterm birth complications were responsible for approximately 1 million deaths in 2020.
Novocuff has developed a groundbreaking medical device to address the complex problems associated with the preterm birth conditions of PPROM and short cervix. The Novocuff Cervical Control System (CCS) has been designed with the goal of stabilizing and closing the cervix to retain amniotic fluid and sustain cervical length, with the aim of extending pregnancy. 
CAUTION - Investigational device. Limited by United States law to investigational use.


Amelia Degenkolb

Donald Lee


Kathryn Wine

VP of Clinical Affairs

Marissa VanDeVeer

Clinical Engineer

Cindy Domecus
Regulatory Affairs



Expecting the Unexpected

Novocuff Joins FI to Help Prevent Preterm Birth

Spotlight: Amelia (Amy) Degenkolb, Ferolyn Fellow

contact us

contact us

Thank you! We'll get back to you asap!

Copyright © 2024 Novocuff

bottom of page